Scynexis Correlations

SCYX Stock  USD 1.20  0.01  0.84%   
The current 90-days correlation between Scynexis and Eagle Pharmaceuticals is -0.08 (i.e., Good diversification). The correlation of Scynexis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Scynexis Correlation With Market

Modest diversification

The correlation between Scynexis and DJI is 0.26 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Scynexis and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scynexis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For more information on how to buy Scynexis Stock please use our How to Invest in Scynexis guide.

Moving together with Scynexis Stock

  0.68ME 23Andme HoldingPairCorr
  0.65JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.8LLY Eli Lilly Sell-off TrendPairCorr
  0.7MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.82PFE Pfizer Inc Aggressive PushPairCorr
  0.83INZY Inozyme PharmaPairCorr
  0.72IPSC Century TherapeuticsPairCorr
  0.72CINGW Cingulate WarrantsPairCorr

Moving against Scynexis Stock

  0.65BMY Bristol Myers Squibb Sell-off TrendPairCorr
  0.48GILD Gilead SciencesPairCorr
  0.67MDGL Madrigal PharmaceuticalsPairCorr
  0.63MNPR Monopar TherapeuticsPairCorr
  0.59RVMD Revolution MedicinesPairCorr
  0.55RNXT RenovoRxPairCorr
  0.54AMLX Amylyx PharmaceuticalsPairCorr
  0.39AKRO Akero TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
TKNOPCRX
TKNOPAHC
EGRXAKAN
PCRXPAHC
CPHIGHSI
EGRXSHPH
  
High negative correlations   
TKNOAKAN
PCRXBFRI
PCRXAKAN
PAHCAKAN
SSICCPHI
PAHCBFRI

Risk-Adjusted Indicators

There is a big difference between Scynexis Stock performing well and Scynexis Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Scynexis' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
BFRI  6.10  0.05  0.00  0.10  0.00 
 14.63 
 46.72 
GHSI  5.47  0.68  0.06 (6.47) 8.11 
 18.66 
 101.05 
SHPH  5.63 (1.03) 0.00  17.64  0.00 
 10.08 
 50.96 
AKAN  3.32 (1.08) 0.00 (0.62) 0.00 
 4.55 
 22.55 
CPHI  4.16  0.12 (0.02) 0.00  4.85 
 9.09 
 43.71 
EGRX  3.94 (1.12) 0.00  1.87  0.00 
 9.24 
 53.71 
PAHC  1.96  0.16  0.13  0.21  1.62 
 5.36 
 15.47 
SSIC  1.09  0.12  0.02  0.60  1.04 
 2.89 
 7.09 
PCRX  1.90  0.22  0.11  0.32  1.95 
 3.96 
 10.38 
TKNO  4.64  0.57  0.12  0.44  5.10 
 12.84 
 32.06 

Scynexis Corporate Management

Debbie EtchisonExecutive CommunicationsProfile
Scott JDChief SecretaryProfile
Marco MDPres CEOProfile
Daniella GiganteVice TechnologyProfile
Christine MBAChief OfficerProfile
David MDChief OfficerProfile